Sunday, September 26, 2021 12:21:44 AM
That's a succinct summary. I would just ad that a big tailwind for cardiac PET and this company's position as the only dedicated cardiac PET maker could allow them to build a significant business here.
They were about a decade early....but the market will finally be coming to them when GE/Lantheus get Fluorpiridaz F-18 approved.
CT scanners are expensive and unnecessary for the cardiac measurements. There's over 25 million cardiology offices that would be better served to get a dedicated PET camera without the CT.
They were about a decade early....but the market will finally be coming to them when GE/Lantheus get Fluorpiridaz F-18 approved.
CT scanners are expensive and unnecessary for the cardiac measurements. There's over 25 million cardiology offices that would be better served to get a dedicated PET camera without the CT.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
Recent POSC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 06:04:15 PM
- Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices • GlobeNewswire Inc. • 02/17/2026 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2025 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 03:21:59 PM
- Positron Corporation Announces Its Transition to a Reporting SEC Company • GlobeNewswire Inc. • 11/17/2025 02:19:08 PM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 11/12/2025 10:04:03 PM
- Positron Corporation Enters Industry Partnership Agreement with MedAxiom • GlobeNewswire Inc. • 10/02/2025 01:15:00 PM
- Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025 • GlobeNewswire Inc. • 10/01/2025 01:15:00 PM
